Skip to main content
KyungdongPharm logo

KyungdongPharm — Investor Relations & Filings

Ticker · 011040 ISIN · KR7011040003 KO Manufacturing
Filings indexed 303 across all filing types
Latest filing 2024-06-17 Major Shareholding Noti…
Country KR South Korea
Listing KO 011040

About KyungdongPharm

https://kdpharma.co.kr

KyungdongPharm is a pharmaceutical company engaged in the development, manufacturing, and distribution of medicines. Since its establishment in 1975, the company has focused on producing a broad portfolio of specialized therapeutic drugs and general pharmaceuticals. Its product lines encompass prescription medicines, with a focus on areas such as liver therapy, and over-the-counter products, including its prominent painkiller brand, 'Geunal-N'. The company also manufactures and supplies active pharmaceutical ingredients (APIs) and intermediates. Utilizing advanced production facilities and proprietary technology, KyungdongPharm is dedicated to developing high-quality medicines supported by clinical research to contribute to public health.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report on the Status of Large Shareholdings' (주식등의 대량보유상황보고서) filed with the Financial Supervisory Service in South Korea. This type of filing is required when an individual or entity acquires a significant stake (typically 5% or more) in a publicly traded company, often referred to as a '5% rule' filing. In the provided taxonomy, this corresponds to a 'Major Shareholding Notification'.
2024-06-17 Korean
분기보고서 (2024.03)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for KyungDong Pharmaceutical Co., Ltd. covering the period from January 1, 2024, to March 31, 2024. It contains detailed financial statements, management discussion and analysis, and operational data, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2024
2024-05-14 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). It details a transaction (purchase of shares) by an executive (Kim Kyung-hoon) of Kyungdong Pharmaceutical Co., Ltd. This is a standard regulatory filing for insider trading/director dealings in the South Korean market, which corresponds to the 'Director's Dealing' category.
2024-05-10 Korean
[기재정정]주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding of Stocks, etc.), which is a regulatory filing in South Korea required under the Capital Markets Act when a person or entity acquires a significant stake (typically 5% or more) in a company. The document explicitly mentions '정정신고' (Correction Report) and details changes in shareholding percentages and special relationship status for Kyungdong Pharmaceutical Co., Ltd. This falls under the category of Major Shareholding Notification.
2024-05-10 Korean
자기주식취득결과보고서
Transaction in Own Shares Classification · 100% confidence The document is a '자기주식취득결과보고서' (Report on the Results of Treasury Stock Acquisition) filed with the Financial Supervisory Service (FSS) in South Korea. It details the specific dates, quantities, and prices of shares repurchased by the company (Kyungdong Pharm) over a defined period. This falls directly under the definition of 'Transaction in Own Shares' (POS), which covers share buybacks.
2024-05-03 Korean
소속부변경
Regulatory Filings Classification · 100% confidence The document is a short, structured announcement regarding a change in the company's listing category (from 'Blue Chip' to 'Mid-sized Enterprise') on the stock exchange. It does not contain full financial statements, proxy materials, or other detailed reports. As it is a regulatory notification regarding company status that does not fit into specific categories like M&A or dividends, it falls under the general regulatory filing category.
2024-04-30 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.